The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: An overview

Haematologica

Volumn 81, Issue 3, 1996, Pages 265-281

  Luppi, Mario ^a   Torelli, Giuseppe ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

HCV; Herpesviruses; Lymphoproliferative diseases

Indexed keywords

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FLAVIVIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOPROLIFERATIVE DISEASE; REVIEW; VIRUS CARCINOGENESIS; VIRUS INFECTION;

HEPACIVIRUS; HERPESVIRIDAE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 0030326589     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46:218-33.
2. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1:702-3.
3. Zur Hausen H, Schulte-Holthausen H, Klein E, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970; 228:1056-8.
4. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320:502-6.
5. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88:4766-70.
6. Klein G. Epstein-Barr virus-carrying cells in Hodgkin's disease. Blood 1992; 80:299-301.
7. Knecht H, Sahli R, Shaw P, et al. Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Haematol 1990; 75:610-4.
8. Weiss L, Jaffe E, Liu X, et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79:1789-95.
9. Peiper S. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-barr virus in pathogenesis. Blood 1993: 82: 687-90.
10. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphoma in patients with lethal midline granuloma. Lancet 1990; 335:128-30.
11. de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T cell lymphomas: differences in relation to site. Blood 1994; 83:1612-8.
12. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84:51-5.
13. Grierson H, Purtilo DT. Epstein-Barr virus infection in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987; 106:538-45.
14. Mac Mahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338:969-73.
15. Shibata D, Weiss LM, Hernandez AM, et al. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993; 91:2101-9.
16. Riddler SA, Breinig MC, McKnight IL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84:972-84.
17. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
18. Yoshida M, Seiki M, Yamaguchi K, et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984; 81:2534-7.
19. Hall WW. Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma. J Exp Med 1994; 180:1581-5.
20. Manca N, Piacentini E, Gelmi M, et al. Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. J Exp Med 1994; 180:1973-8.
21. Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. J Clin Invest 1995; 95:547-54.
22. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
23. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234:596-600.
24. Josephs SF, Salahuddin SZ, Ablashi DV, et al. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 1986; 234:601-3.
25. Ablashi D, Agut H, Berneman Z, et al. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 1993; 129:363-6.
26. Lusso P, Markham PD, Tschachler E, et al. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus 6). J Exp Med 1988; 167:1659-70.
27. Lusso P, Malnati MS, Garzino-Demo, et al. Infection of natural killer cells by human herpesvirus-6. Nature 1993; 337:370-3.
28. Pellett PE, Black JB, Yamamoto M. Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv Virus Res 1992; 41:1-52.
29. Okuno T, Takahashi K, Balachandran K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27:651-3.
30. Yamanishi K, Okuno T, Shiraki T, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; i:1065-7.
31. Pruksananonda P, Breese-Hall C, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992; 326:1445-50.
32. Irving WL, Cunnigham AL. Serological diagnosis of infection with human herpesvirus type 6. Br Med J 1990; 300:156-9.
33. Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus 6 (HHV-6) in patients with mononucleosis-like illness not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990; 93:776-83.
34. Gopal MR, Thomson BJ, Fox J, et al. Detection by PCR of HHV-6 and EBV DNA in blood and in oropharynx of healthy adults and HIV seropositives. Lancet 1990; 335:1598-9.
35. Jarrett RF, Clark DA, Josephs SF, et al. Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol 1990; 32:73-6.
36. Luppi M, Barozzi P, Marasca R, et al. Human herpesvirus-6 (HHV-6) in blood donors. Br J Haematol 1995; 89:943-5.
37. Fox JD, Briggs M, Ward PA, et al. Human herpesvirus 6 in salivary glands. Lancet 1990; 336:590-3.
38. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994; 169: 943-4.
39. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol 1995; 47:105-11.
40. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple scerosis. Proc Natl Acad Sci USA 1995; 92: 7440-4.
41. Luppi M, Marasca R, Barozzi P, et al. Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol 1993; 40:44-52.
42. Torelli G, Barozzi P, Marasca R, et al. Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995; 46:178-88.
43. Fioretos T, Heisterkamp N, Groffen J, et al. CRK proto-oncogene maps to human chromosome band 17p 13. Oncogene 1993; 8: 2853-5.
44. Razzaque A. Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990; 5: 1365-70.
45. Razzaque A, Williams O, Wang J, et al. Neoplastic transformation of immortalized human epidermal keratinocytes by two HHV-6 DNA clones. Virology 1993; 195:113-20.
46. Thompson J, Choudhury S, Kashanchi F, et al. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 1994; 9 167-75.
47. Thomson BJ, Efsathiou S, Honess RW. Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 1991; 351:78-80.
48. Araujo JC, Doniger J, Kashanchi F, et al. Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters. J Virol 1995; 69: 4933-40.
49. Clark DA, Alexander FE, McKinney PA, et al. The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma. Int J Cancer 1990; 45:829-33.
50. Torelli G, Marasca R, Luppi M, et al. Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 1991; 77:2251-8.
51. Levine PH, Ebbesen P, Ablashi DV, et al. Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer 1992; 51: 53-7.
52. Torelli G, Marasca R, Montorsi M, et al. Human herpesvirus 6 in non-AIDS related Hodgkin's and non Hodgkin's lymphomas. Leukemia 1992; 6:46S-8S.
53. Di Luca D, Dolcetti R, Mirandola P, et al. Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 1994; 170:211-5.
54. Luppi M, Barozzi P, Marasca R, et al. Integration of human herpesvirus-6 genome in chromosome 17 in two lymphoma patients. Leukemia 1994; 8:41S-5S.
55. Luppi M, Barozzi P, Marasca R, et al. Characterization of human herpesvirus-6 genomes from cases of latent infection in human lymphomas and immune disorders. J Infect Dis 1993; 168:1074-5.
56. Trovato R, Luppi M, Vago L, et al. Frequency of human herpesvirus type 6 (HHV-6) genome detection in AIDS-related lymphoproliferative disorders. J Acq Immune Def Synd 1995; 9:311-2.
57. Josephs SF, Buchbinder A, Streicher HZ, et al. Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. Leukemia 1988; 2:132-5.
58. Jarrett RF, Glehill S, Qureshi F, et al. Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988; 2:496-502.
59. Luppi M, Marasca R, Barozzi P, et al. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leu Res 1993; 17:1003-11.
60. Flamand I, Stefanescu I, Ablashi DV, et al. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993; 67:6768-77.
61. Flamand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1 and tumor necrosis factor alpha, but not interleukin-6 in peripheral blood mononuclear cell cultures. J Virol 1991; 65: 5105-10.
62. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995; 85:1263-71.
63. Braun DK, Pellett PE, Hanson CA. Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T-cell chronic lymphoproliferative disease. J Infect Dis 1995; 171:1351-5.
64. Tagawa S, Mizuki M, Onoi U, et al. Transformation of large granular lymphocytic leukemia during the course of a reactivated human herpesvirus-6 infection. Leukemia 1992; 6:465-9.
65. Levine PH, Jahan N, Murari P, et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992; 166:291-5.
66. Ablashi DV, Josephs SF, Buchbinder A, et al. Human B lymphotropic virus (human herpesvirus-6). J Virol Meth 1988; 21: 29-48.
67. Levine PH, Ablashi DV, Saxinger WC, et al. Antibodies to human herpesvirus-6 in patients with acute lymphocytic leukemia. Leukemia 1992; 6: 1229-31.
68. Luka J, Pirruccello SJ, Kersey JH. HHV-6 genome in T-cell acute lymphoblastic leukaemia. Lancet 1991; 338:1277-8.
69. Barozzi P, Luppi M, Marasca R, et al. Human herpesvirus-6 (HHV-6) genome in acute lymphoblastic leukemia: evidence against an etiologic role. Acta Haematol 1995; 94:169-72.
70. Morris JDH, Eddleston ALWF, Crook T. Viral infection and cancer. Lancet 1995; 346:754-8.
71. Marx JL. How DNA viruses may cause cancer. Science 1989; 243:1012-3.
72. Frenkel N, Schirmer EC, Katsafanas G, et al. Isolation of a new herpesvirus from human CD4+ T cells, Proc Natl Acad Sci USA 1990; 87:748-52.
73. Berneman Z, Gallo RC, Ablashi DV, et al. Human herpesvirus 7 (HHV-7) strain II: independent confirmation of HHV-7. J Infect Dis 1992; 166:690-1.
74. Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992; 66:3206-9.
75. Lusso P, Secchiero P, Crowley RW, et al. CD4 is a critical component of the receptor for human herpesvirus 7: inteference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994; 91:3872-6.
76. Kawa-Ha K, Tanaka K, Inoue M, et al. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br J Haematol 1993; 84:545-8.
77. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
78. Levy JA, A new human herpesvirus: KSHV or HHV-8? Lancet 1995; 346:786.
79. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332:1181-5.
80. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345:759-61.
81. Schalling M, Ekman M, Kaaya EE, et al. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Medicine 1995; 1:707-8.
82. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med 1996; 156:202-4.
83. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345:1043-4.
84. Luppi M, Barozzi P, Maiorana A, et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from Italian population. Int J Cancer 1996; in press.
85. Noel JC. Kaposi's sarcoma and KSHV. Lancet 1995; 346:1359.
86. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Medicine 1995; 1:1274-8.
87. Cesarman E, Chang Y, Moore P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based Iymphomas. N Engl J Med 1995; 332:1186-91.
88. Pastore C, Gloghini A, Volpe G, et al. Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br J Haematol 1995; 91:918-20.
89. Nador RG, Cesarman E, Knowles DM, et al. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient.(letter). N Engl J Med 1995; 333:943.
90. Cesarman E, Nador R, Knowles DM (reply). Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. N Engl J Med 1996; 334:272-3.
91. Cesarman E, Moore PS, Rao PH, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995; 86:2708-14.
92. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-8 (HHV-8) DNA sequences in HIV negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87:3903-9.
93. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-80.
94. Gessain A, Sudaka A, Brière J, et al. Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87:414-6.
95. Karcher DS, Alkan S, Dupin N, et al. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med 1995; 333:797-9.
96. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20:636-47.
97. Steinberg AD, Seldin MF, Jaffe ES, et al. NIH Conference. Angioimmunoblastic lymphadenopathy with dysproteine-mia. Ann Intern Med 1988; 108:575-84.
98. Krishnan J, Danon AD, Frizzera G. Reactive lymphadenopathies and atypical lymphoproliferative disorders. Am J Clin Pathol 1993; 99:385-96.
99. Ford R, Tamayo A, Martin B, et al. Identification of B-cell growth factors (interleukin-14; high molecular weight B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas. Blood 1995; 86:283-93.
100. Ambroziak JA, Blackbourn DJ, Herndier B, et al. Herpes-virus-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268:582-3.
101. Lin J-C, Lin S-C, Mar E-C, et al. Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995; 346:1601-2.
102. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995; 345:1339-40.
103. Gluckman E, Parquet N, Scieux C, et al. KS-associated herpesvirus-like DNA sequences after allogenic bone-marrow transplantation. Lancet 1995; 346:1588-9.
104. Luppi M, Barozzi P, Marasca R, et al.HHV-8-associated primary cerebral B-cell lymphoma in an HIV-negative patient after long-term steroids. Lancet 1996; 347:980.
105. Zijlmans JMJM, van Rijthoven AWAM, Kluin PM, et al. Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cydosporine. N Engl J Med 1992; 326:1363.
106. Kamel OW, van de Rijin M, Weiss LM, et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328:1317-21.
107. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62.
108. van der Poel C, Cuypers HT, Reesnik HW. Hepatitis C virus six years on. Lancet 1994; 344:1475-9.
109. Alter HJ. To C or not to C: these are the questions. Blood 1995; 85:1681-95.
110. Houghton M, Weiner AJ, Han J, et al. Molecular biology of the hepatitis C viruses: implication for diagnosis, development and control of viral disease. Hepatology 1991; 14:382-8.
111. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genomes. Hepatology 1994; 19:1321-4.
112. Nousbaum J-P, Pol S, Nalpas B, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122; 161-8.
113. Martin P. Hepatitis C genotypes: the key to pathogenicity?. Ann Intern Med 1995; 122:227-8.
114. Shindo M, Arai K, Sokawa Y, et al. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-therapy. Ann Intern Med 1995; 122:586-91.
115. van der Poel CL, Cuypers HTM, Reesnik HW, et al. Confirmation of hepatitis C virus infection by second generation four-antigen recombinant immunoblot assay and polymerase chain reaction. Lancet 1991; 337:317-9.
116. van der Poel CL, Cuypers HTM, Reesnik HW, et al. Risk factors in HCV infected blood donors. Transfusion 1991; 31:777-9.
117. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward. Lancet 1995; 345:603-7.
118. Alter HJ, Purcell RH, Shih JW. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321:1494-500.
119. Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338:277-80.
120. Magrin S, Craxi A, Fabiano C, et al. Hepatitis C viral replication in "autoimmune" chronic hepatitis. J Hepatol 1991; 13:364-7.
121. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345:413-5.
122. Shimizu Y-K, Iwamoto A, Hijikata M, et al. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line Proc Natl Acad Sci USA 1992; 89:5477-81.
123. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15:382-6.
124. Ferri C, La Civita L, Longobardo G, et al. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 1993; 23:399-405.
125. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123:615-20.
126. Miescher PA, Huang Y-P, Izui S. Type II cryoglobulinemia. Semin Hematol 1995; 32:80-5.
127. Agnelle V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-5.
128. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82:3701-4.
129. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma hepatitis C virus infection and mixed cryoglobulinemia. Blood 1994; 84:3047-53.
130. Ferri C, Monti M, La Civita, et al. Hepatitis C virus infection in non-Hodgkin's B cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994; 24:781-4.
131. Ellis M, Rathaus M, Amiel A, et al. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Eur J Clin Invest 1995; 25:833-7.
132. Casato M, Lagana B, Antonelli G, et al. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991; 78:3142-7.
133. Ferri C, Marzo E, Longobardo G, et al. α-interferon in mixed cryoglobulinemia patients: a randomized crossover controlled trial. Blood 1993; 81:1132-6.
134. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334:77-81.
135. Ferri C, La Civita L, Monti M, et al. Can type C hepatitis infection be complicated by malignant lymphoma? Lancet 1995; 346:1426-7.
136. Santini GF, Crovatto M, Modolo ML, et al. Waldenström macroglobulinemia: a role of HCV infection? Blood 1993; 82:2932.
137. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88:392-4.
138. Cavanna L, Sbolli G, Tanzi E, et al. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica 1995; 80:486-7.
139. Luppi M, Ferrari MG, Bonaccorsi G, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10:351-5.
140. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20:1442-9.
141. Franzin F, Efremov DG, Pozzato G, et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90:548-52.
142. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69:3893-6.
143. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86:1887-92.
144. Fox RI, Luppi M, Kang HI, et al. Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Semin Immunopathol 1991; 13:217-31.
145. Cinque P, Brytting M, Vago L, et al. Epstein-barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the cerebral central nervous system. Lancet 1993; 342:398-401.
146. Roth G, Curiel T, Lacy J. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 1994; 84:582-7.
147. Papadopoulos EB, Ladanyl M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330:1185-91.
148. Lieberman J, Buchsbaum RJ. Using T cells to treat B-cell cancers. N Engl J Med 1994; 330:1231-3.
149. Rooney CM, Smith CA, Ng CYC, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 1995; 345:9-13.
150. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87:2211-5.
151. Samulski RJ, Zhu X, Xiao X, et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991; 10:3941-50.
152. Goodman S, Xiao X, Donahue RE, et al. Recombinant adenoassociated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 1994; 84:1492-500.
153. Walsh CE, Nienhuis AW, Samulski RJ, et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994; 94:1440-8.
154. Luo F, Zhou SZ, Cooper S, et al. Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1995; 23:1261-7.
155. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-3.
156. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346:799-802.
157. Shiramizu B, Herndier BG, Mc Grath MS. Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Res 1995; 54:2069-72.
158. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 1996; 2:342-6.